Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma

Blood Adv. 2020 Jul 14;4(13):3123-3127. doi: 10.1182/bloodadvances.2020002328.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunotherapy, Adoptive
  • Interleukin 1 Receptor Antagonist Protein
  • Lymphoma, B-Cell*
  • Receptors, Chimeric Antigen*
  • Treatment Outcome

Substances

  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Chimeric Antigen